Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled "Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India".
Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled "Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India".